Mitotic bypass via an occult cell cycle phase following DNA topoisomerase II inhibition in p53 functional human tumor cells

Cell Cycle

Volumn 6, Issue 16, 2007, Pages 2071-2081

  Smith, Paul J ^a   Marquez, Nuria ^a,b   Wiltshire, Marie ^a   Chappell, Sally ^a   Njoh, Kerenza ^a   Campbell, Lee ^a   Khan, Imtiaz A ^a   Silvestre, Oscar ^a   Errington, Rachel J ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Chromosomal instability; Cyclin B1; Decatenation checkpoint; DNA topoisomerase II; Endocycle; ICRF 193; Mitosis; TP53

Indexed keywords

CYCLIN B1; DNA TOPOISOMERASE (ATP HYDROLYSING); PACLITAXEL; PROTEIN P53;

ARTICLE; CELL CYCLE G2 PHASE; CELL NUCLEUS MEMBRANE; CONTROLLED STUDY; ENZYME INHIBITION; HUMAN; HUMAN CELL; MITOSIS SPINDLE; PROTEIN FUNCTION; PROTEIN INDUCTION; TETRAPLOIDY; TUMOR CELL;

EID: 34548314311     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.6.16.4585     Document Type: Article

References (40)

1. Sieber OM, Heinimann K, Tomlinson IPM. Genomic instability - The engine of tumorigenesis? Nat Rev Cancer 2003; 3:701-8.
2. Shi Q, King RW. Chromosome nondisjunction yields tetraploid rather than aneuploid cells in human cell lines. Nature 2005; 437:1038-44, [Comment in: Nature 2006; 442:E9-10].
3. Bharadwaj R, Yu H. The spindle checkpoint, aneuploidy, and cancer. Oncogene 2004; 23:2016-27.
4. Grafi G. Cell cycle regulation of DNA replication: The endoreduplication perspective. Exp Cell Res 1998; 244:372-8.
5. Erenpreisa J, Cragg MS. Mitotic death: A mechanism of survival? A review. Cancer Cell Int 2001; 1.
6. Andrews CA, Vas AC, Meier B, Gimenez-Abian JF, Diaz-Martinez LA, Green J, Erickson SL, Vanderwaal KE, Hsu WS, Clarke DJ. A mitotic topoisomerase II checkpoint in budding yeast is required for genome stability but acts independently of Pds1/securing. Genes Dev 2006; 20:1162-74.
7. Germe T, Hyrien O. Topoisomerase II-DNA complexes trapped by ICRF-193 perturb chromatin structure. EMBO Rep 2005; 6:729-35.
8. 2 cycle checkpoint in mammalian cells. Nature 1994; 372:467-70.
9. Deming PB, Cistulli CA, Zhao H, Graves PR, Piwnica-Worms H, Paules RS, Downes CS, Kaufmann WK. The human decatenation checkpoint. Proc Natl Acad Sci USA 2001; 98:12044-9.
10. Damelin M, Bestor TH. The decatenation checkpoint. Br J Cancer 2007; 96:201-205.
11. Ishida R, Hamatake M, Wasserman RA, Nitiss JL, Wang JC, Andoh T. DNA topoisomerase II is the molecular target of bisdioxopiperazine derivatives ICRF-159 and ICRF-193 in Saccharomyces cerevisiae. Cancer Res 1995; 55:2299-303.
12. Pastor N, Jose Flores M, Dominguez I, Mateos S, Cortes F. High yield of endoreduplication induced by ICRF-193: A topoisomerase II catalytic inhibitor. Mutat Res 2002; 516:113-20.
13. Ishida R, Sato M, Narita T, Utsumi KR, Nishimoto T, Morita T, Nagata H, Andoh T. Inhibition of DNA topoisomerase II by ICRF-193 induces polyploidization by uncoupling chromosome dynamics from other cell cycle events. J Cell Biol 1994; 126:1341-51.
14. 2 checkpoint through inhibition of Plk1 kinase. Journal of Biological Chemistry 2002; 277:36832-8.
15. 2-phase decatenation checkpoint is defective in Werner syndrome cells. Cancer Research 2003; 63:3289-95.
16. 2/M checkpoint response induced by the catalytic topoisomerase II inhibitor ICRF-193. Cell Cycle 2007; 6:1265-7.
17. Campbell KJ, Chapman NR, Perkins ND. UV stimulation induces nuclear factor B (NF-B) DNA-binding activity but not transcriptional activation. Biochem Soc Trans 2001; 29:688-91.
18. Falk SJ, Smith PJ. DNA damaging and cell cycle effects of the topoisomerase I poison camptothecin in irradiated human cells. Int J Radiat Biol 1992; 61:749-57.
19. Thomas N, Kenrick M, Giesler T, Kiser G, Tinkler H, Stubbs S. Characterization and gene expression profiling of a stable cell line expressing a cell cycle GFP sensor. Cell Cycle 2005; 4:191-5.
20. Wyllie FS, Haughton MF, Rowson JM, Wynford-Thomas D. Human thyroid cancer cells as a source of iso-genic, iso-phenotypic cell lines with or without functional p53. Br J Cancer 1999; 79:1111-20.
21. Jones CJ, Soley A, Skinner JW, Gupta J, Haughton MF, Wyllie FS, Schlumberger M, Bacchetti S, Wynford-Thomas D. Dissociation of telomere dynamics from telomerase activity in human thyroid cancer cells. Exp Cell Res 1998; 240:333-9.
22. McSharry BP, Jones CJ, Skinner JW, Kipling D, Wilkinson GW. Human telomerase reverse transcriptase-immortalized MRC-5 and HCA2 human fibroblasts are fully permissive for human cytomegalovirus. J Gen Virol 2001; 82:855-63.
23. 1 peak. Cytometry 1987; 8:1-8.
24. Smith PJ, Blunt N, Wiltshire M, Hoy T, Teesdale-Spittle P, Craven MR, Watson JV, Amos WB, Errington RJ, Patterson LH. Characteristics of a novel deep red/infrared fluorescent cell-permeant DNA probe, DRAQ5, in intact human cells analyzed by flow cytometry, confocal and multiphoton microscopy. Cytometry 2000; 40:280-91.
25. 2 checkpoint. Oncogene 2003; 22:7642-8.
26. Errington RJ, Marquez N, Chappell SC, Wiltshire M, Smith PJ. Time-lapse microscopy approaches to track cell cycle progression at the single-cell. In: Robinson JP, ed. Current Protocols in Cytometry. Wiley Interscience, 2006, (ISBN: 978-0-471-16131-8).
27. Clute P, Pines J. Temporal and spatial control of cyclin B1 destruction in metaphase. Nat Cell Biol 1999; 1:82-7.
28. Thomas N, Kenrick M, Giesler T, Kiser G, Tinkler H, Stubbs S. Characterization and gene expression profiling of a stable cell line expressing a cell cycle GFP sensor. Cell Cycle 2005; 4:191-5.
29. Allman R, Errington RJ, Smith PJ. Delayed expression of apoptosis in human lymphoma cells undergoing low-dose taxol-induced mitotic stress. Brit J Can 2003; 88:1649-58.
30. Marquez N, Chappell SC, Sansom OJ, Clarke AR, Teesdale-Spittle P, Errington RJ, Smith PJ. Microtubule stress modifies intra-nuclear location of Msh2 in mouse embryonic fibroblasts. Cell Cycle 2004; 3:662-71.
31. Smith PJ, Makinson TA. Cellular consequences of overproduction of DNA topoisomerase II in an ataxia-telangiectasia cell line. Cancer Res 1989; 49:1118-24.
32. Kaufmann WK, Campbell CB, Simpson DA, Deming PB, Filatov L, Galloway DA, Zhao XJ, Creighton AM, Downes CS. Degradation of ATM-independent decatenation checkpoint function in human cells is secondary to inactivation of p53 and correlated with chromosomal destabilization. Cell Cycle 2002; 1:210-9.
33. 2/M transition by p53. Oncogene 2001; 20:1803-15.
34. Park I, Avraham HK. Cell cycle-dependent DNA damage signaling induced by ICRF-193 involves ATM, ATR, CHK2, and BRCA1. Experimental Cell Research 2006; 312:1996-2008.
35. Tyson JJ. Monitoring p53's pulse. Nat Genet 2004; 36:113-4.
36. Liu JS, Kuo SR, Melendy T. DNA damage-induced RPA focalization is independent of gamma-H2AX and RPA hyper-phosphorylation. J Cell Biochem 2006; 99:1452-62.
37. Uetake Y, Sluder G. Cell cycle progression after cleavage failure: Mammalian somatic cells do not possess a "tetraploidy checkpoint". J Cell Biol 2004; 165:609-15.
38. Blagosklonny MV. Prolonged mitosis versus tetraploid checkpoint: How p53 measures the duration of mitosis. Cell Cycle 2006; 5:971-5.
39. 1-S arrest. Nature Cell Biology 2007; 9:160-70.
40. Cortes F, Mateos S, Pastor N, Domýnguez I. Toward a comprehensive model for induced endoreduplication. Life Sciences 2004; 76:121-35.